Corvus Pharmaceuticals CRVS Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's common stock?
- Corvus Pharmaceuticals (CRVS) reported common stock of $8K in Q1 2026.
- How has Corvus Pharmaceuticals's common stock changed year-over-year?
- Corvus Pharmaceuticals's common stock increased by 14.3% year-over-year, from $7K to $8K.
- What is the long-term trend for Corvus Pharmaceuticals's common stock?
- Over 5 years (2020 to 2025), Corvus Pharmaceuticals's common stock has grown at a 18.5% compound annual growth rate (CAGR), from $3K to $7K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).